Preparing for Disease‐Modification Trials in Degenerative Cerebellar Ataxias: Which Endpoints to Choose?
Movement Disorders · 2023
DOI: 10.1002/mds.29388 ↗Kurz gefasst
Editorial in der Zeitschrift Movement Disorders, 2023. Verfasst von Roderick P P W M Maas. Beteiligte Einrichtung: Department of Neurology, Donders Institute for Brain, Cognition, and Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands. Hauptthemen laut MEDLINE: Cerebellar Ataxia, Spinocerebellar Ataxias, Friedreich Ataxia. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 33 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology, Donders Institute for Brain, Cognition, and Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands.
ORCID-Profile: Roderick P P W M Maas
Zitieren
APA
Maas, R. P. P. W. M. (2023). Preparing for Disease‐Modification Trials in Degenerative Cerebellar Ataxias: Which Endpoints to Choose?. Movement Disorders. https://doi.org/10.1002/mds.29388
Vancouver
Maas RPPWM. Preparing for Disease‐Modification Trials in Degenerative Cerebellar Ataxias: Which Endpoints to Choose?. Movement Disorders. 2023. doi:10.1002/mds.29388
BibTeX
@article{Maas2023,
author = {Maas, Roderick P P W M},
title = {Preparing for Disease‐Modification Trials in Degenerative Cerebellar Ataxias: Which Endpoints to Choose?},
journal = {Movement Disorders},
year = {2023},
doi = {10.1002/mds.29388}
}
EUVIMED